C4X Discovery Holdings (LON:C4XD) First Half 2023 Results

Key Financial Results

• Revenue: UK£1.68m (up by UK£1.61m from 1H 2022).

• Net loss: UK£3.88m (loss narrowed by 14% from 1H 2022).

• UK£0.015 loss per share (improved from UK£0.02 loss in 1H 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

C4X Discovery Holdings Earnings Insights

Looking ahead, revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Life Sciences industry in the United Kingdom.

Performance of the British Life Sciences industry.

The company's shares are down 5.3% from a week ago.

Risk Analysis

Be aware that C4X Discovery Holdings is showing 3 warning signs in our investment analysis and 1 of those is a bit concerning...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here